Pacific Biosciences Of California (PACB) Enterprise Value (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Enterprise Value of -$276.0 million for Q1 2026, up 19.57% year-over-year from -$230.8 million in Q1 2025, and down 333.04% quarter-over-quarter from -$63.7 million in Q4 2025.
Pacific Biosciences Of California (PACB) Enterprise Value (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Enterprise Value history runs 17 years deep, the most recent figure standing at -$276.0 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 19.57% year-over-year to -$276.0 million; the TTM figure through Mar 2026 stood at -$276.0 million (up 19.57% YoY), while the FY2025 annual figure was -$63.7 million, down 2088.43% from the prior year.
- Enterprise Value for Q1 2026 stood at -$276.0 million, down from -$63.7 million in the prior quarter.
- The five-year high for Enterprise Value was -$2.9 million in Q4 2024, with the low at -$874.9 million in Q1 2023.
- The 5-year median for Enterprise Value is -$343.1 million (2025), against an average of -$353.8 million.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value soared 99.33% in 2023, then plunged 13551.22% in 2024.
- Pacific Biosciences Of California's Enterprise Value stood at -$450.5 million in 2022, then jumped by 99.33% to -$3.0 million in 2023, then increased by 3.64% to -$2.9 million in 2024, then slumped by 2088.43% to -$63.7 million in 2025, then tumbled by 333.04% to -$276.0 million in 2026.
- Business Quant data shows PACB's Enterprise Value at -$276.0 million in Q1 2026, -$63.7 million in Q4 2025, and -$244.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | -236.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -236.87 Mn |
| Mar 31, 2026 | -275.96 Mn |
| Dec 31, 2025 | -63.73 Mn |
| Sep 30, 2025 | -244.02 Mn |
| Jun 30, 2025 | -314.74 Mn |
| Mar 31, 2025 | -343.11 Mn |
| Dec 31, 2024 | -2.91 Mn |
| Sep 30, 2024 | -395.39 Mn |
| Jun 30, 2024 | -412.54 Mn |
| Mar 31, 2024 | -561.91 Mn |
| Dec 31, 2023 | -3.02 Mn |
| Sep 30, 2023 | -384.86 Mn |
| Jun 30, 2023 | -3.02 Mn |
| Mar 31, 2023 | -874.89 Mn |
| Dec 31, 2022 | -450.45 Mn |
| Sep 30, 2022 | -834.34 Mn |
| Jun 30, 2022 | -310.75 Mn |
| Mar 31, 2022 | -539.68 Mn |
| Dec 31, 2021 | -5.59 Mn |
| Jun 30, 2021 | -3.60 Mn |